Workflow
板蓝根
icon
Search documents
“苦”药材变“甜”产业
Jin Rong Shi Bao· 2025-08-26 02:34
八月骄阳炽热如火,田野里银柴胡翻涌着绿浪,黄芩绽放着蓝紫色的小花。记者来到宁夏同心县中药材 种植基地,被郁郁葱葱的银柴胡、黄芩、板蓝根等药材吸引。 针对小微企业中药材信贷产品不多,融资渠道单一的情况,中国人民银行吴忠市分行同心营管部引导辖 内银行业金融机构创新推出中药材专属信贷产品,在利率、期限、抵押物等方面出台优惠支持举措,不 断加大信贷投入,切实解决信贷占比偏低和中药材产业发展过程中的卡点、堵点问题,全面提升和壮大 本土中药材企业、合作社、种植大户生产能力。 因扩大柴胡和黄芩种植规模,同心县马高庄乡的泉蚨种植专业合作社急需流动资金100万元,当地农商 银行了解情况后,利用"小微通"专属信贷产品及时为合作社办理了90万元流动资金循环贷款,有效解决 了合作社的燃眉之急。通过"基地+合作社+农户+金融机构"的联农带农机制,合作社今年又培育带动 178户群众参与种植、319户脱贫户发展庭院经济,户均年增收6000元。 "现在合作社真是给老百姓解决了大难题,以前农户需要自己摸索种植技术,产量上不去,销路也没保 障,辛辛苦苦忙活一年也挣不了几个钱。"当地政府农业技术人员李海洋告诉记者,如今合作社不仅提 供全程技术指导 ...
官宣!李楚源,被“双开”!同时撤销荣誉称号
第一财经· 2025-05-17 08:19
Core Viewpoint - The article discusses the serious disciplinary violations and illegal activities of Li Chuyuan, the former Party Secretary and Chairman of Guangzhou Pharmaceutical Group Co., Ltd., leading to his expulsion from the Party and removal from public office [2][3]. Group 1: Disciplinary Actions - Li Chuyuan was expelled from the Party and removed from public office due to severe violations of political, organizational, and ethical disciplines, constituting serious job-related crimes [3]. - His illegal activities included engaging in superstitious practices, misuse of public resources, and accepting bribes, which were investigated by the Guangdong Provincial Commission for Discipline Inspection [2][3]. Group 2: Company Background - Guangzhou Pharmaceutical Group Co., Ltd. is a state-owned enterprise authorized by the Guangzhou government, involved in the research, production, and sales of traditional Chinese medicine, chemical drugs, and health products [5]. - The company operates several well-known brands, including "Wanglaoji" and "Baiyunshan," with significant brand values of 108 billion and 28.3 billion respectively [5]. Group 3: Li Chuyuan's Career - Li Chuyuan has held various positions within the company since 1988, eventually becoming the Chairman in 2013, and has been recognized with multiple awards and honors throughout his career [6][7]. - His public statements during events, particularly regarding the efficacy of the company's products, have sparked controversy and debate [7].